Page last updated: 2024-08-23

moxalactam and Bacteremia

moxalactam has been researched along with Bacteremia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, M; Kunii, O; Miyashita, H; Miyashita, T; Nishiya, H; Ohyatsu, I; Ono, Y; Sekino, N; Sugiyama, H; Tokumura, Y1
Boas, J; Bruun, BG; Dombernowsky, P; Frimodt-Møller, N; Hansen, HH; Hansen, OP; Holländer, NH; Oturai, PS1
Katoh, H; Nagamachi, Y; Shiojima, M; Takenoshita, S; Tsukada, K1
Bourquelot, P; Bouscary, D; Dreyfus, F; Paul, G; Picard, F; Tulliez, M; Varet, B1
Baquero, F; Canton, R; Gomez-Alferez, A; Loza, E; Martinez-Beltran, J1

Reviews

1 review(s) available for moxalactam and Bacteremia

ArticleYear
[Two cases of Campylobacter fetus subsp. fetus sepsis].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1994, Volume: 68, Issue:2

    Topics: Bacteremia; Campylobacter fetus; Campylobacter Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Moxalactam

1994

Trials

1 trial(s) available for moxalactam and Bacteremia

ArticleYear
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Bacteremia; Bacterial Infections; Ceftriaxone; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neutropenia; Prospective Studies; Respiratory Tract Infections; Urinary Tract Infections

1993

Other Studies

3 other study(ies) available for moxalactam and Bacteremia

ArticleYear
Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1993, Volume: 101, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; Endothelins; Endotoxins; Escherichia coli Infections; Injections, Intraperitoneal; Moxalactam; Peritonitis; Prognosis; Rats; Rats, Wistar; Survival Analysis

1993
Hemophagocytic syndrome associated with Bacteroides fragilis infection in a patient with acute monoblastic leukemia.
    Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2

    Topics: Amikacin; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Ceftazidime; Cytarabine; Daunorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Leukemia, Monocytic, Acute; Middle Aged; Moxalactam; Tonsillitis; Vancomycin

1996
The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:5

    Topics: Ampicillin Resistance; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Phenotype; Proteus Infections; Proteus vulgaris; Spain; Urinary Tract Infections

1991